Marvin Xavierselvan

Dr. Marvin Xavierselvan

Biomedical Engineering, Tufts University, Medford, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Sensors
Verified
Journal Article
Open access
PDF file
RBRianne Bulsink
Rianne Bulsink
Mithun Kuniyil Ajith SinghMithun Kuniyil Ajith Singh
Mithun Kuniyil Ajith Singh
MXMarvin Xavierselvan
Marvin Xavierselvan
Srivalleesha MallidiSrivalleesha Mallidi
Srivalleesha Mallidi
WSWiendelt Steenbergen
Wiendelt Steenbergen
FJFrancis Kalloor Joseph
Francis Kalloor Joseph
Oxygen saturation imaging has potential in several preclinical and clinical applications. Dual-wavelength LED array-based photoacoustic oxygen saturation imaging can be an affordable solution in this case. For the translation of this technology, there is a need to improve its accuracy and validate it against ground truth methods. We propose a fluence compensated oxygen saturation imaging method, utilizing structural information from the ultrasound image, and prior knowledge of the optical properties of the tissue with a Monte-Carlo based light propagation model for the dual-wavelength LED array configuration. We then validate the proposed method with oximeter measurements in tissue-mimicking phantoms. Further, we demonstrate in vivo imaging on small animal and a human subject. We conclude that the proposed oxygen saturation imaging can be used to image tissue at a depth of 6–8 mm in both preclinical and clinical applications.

12 August 2020 in Sensors
Verified
Journal Article
Open access
PDF file
MXMarvin Xavierselvan
Marvin Xavierselvan
Mithun Kuniyil Ajith SinghMithun Kuniyil Ajith Singh
Mithun Kuniyil Ajith Singh
Srivalleesha MallidiSrivalleesha Mallidi
Srivalleesha Mallidi
Photoacoustic (PA) imaging has shown tremendous promise for imaging tumor vasculature and its function at deeper penetration depths without the use of exogenous contrast agents. Traditional PA imaging systems employ expensive and bulky class IV lasers with low pulse repetition rate, due to which its availability for preclinical cancer research is hampered. In this study, we evaluated the capability of a Light-Emitting Diode (LED)-based PA and ultrasound (US) imaging system for monitoring heterogeneous microvasculature in tumors (up to 10 mm in depth) and quantitatively compared the PA images with gold standard histology images. We used a combination of a 7 MHz linear array US transducer and 850 nm excitation wavelength LED arrays to image blood vessels in a subcutaneous tumor model. After imaging, the tumors were sectioned and stained for endothelial cells to correlate with PA images across similar cross-sections. Analysis of 30 regions of interest in tumors from different mice showed a statistically significant R-value of 0.84 where the areas with high blood vessel density had high PA response while low blood vessel density regions had low PA response. Our results confirm that LED-based PA and US imaging can provide 2D and 3D images of tumor vasculature and the potential it has as a valuable tool for preclinical cancer research.

15 April 2020 in Particle & Particle Systems Characterization
Verified
Journal Article
Closed access
PDF file
SHSabrina S. Hafiz
Sabrina S. Hafiz
DLDaniela Labadini
Daniela Labadini
RRRyan Riddell
Ryan Riddell
EWErich P. Wolff
Erich P. Wolff
MXMarvin Xavierselvan
Marvin Xavierselvan
MFMichelle Foster
Michelle Foster

11 April 2019 in ACS Sensors
Verified
Journal Article
Closed access
JMJennifer M. Morales
Jennifer M. Morales
RPRobert H. Pawle
Robert H. Pawle
NANamik Akkilic
Namik Akkilic
YLYi Luo
Yi Luo
MXMarvin Xavierselvan
Marvin Xavierselvan
HCHeather A. Clark
Heather A. Clark

28 February 2020 in Journal of Biomedical Optics
Verified
Journal Article
Open access
LPLjubica Z. Petrovic
Ljubica Z. Petrovic
MXMarvin Xavierselvan
Marvin Xavierselvan
MKMaju Kuriakose
Maju Kuriakose
MKMichael D. Kennedy
Michael D. Kennedy
CNChristopher D. Nguyen
Christopher D. Nguyen
Srivalleesha MallidiSrivalleesha Mallidi
Srivalleesha Mallidi
Photodynamic therapy (PDT), a spatially localized phototoxic therapy that involves irradiation of a photosensitizer (PS) with specific wavelengths of light, has shown exceptional promise in impacting cancer treatment outcomes, particularly oral cancer. To reduce PDT outcome variability, attempts toward image-guided personalized PDT are being pursued by monitoring PS uptake either via fluorescence or photoacoustic imaging (PAI), a nonionizing modality dependent on optical absorption properties of the tissue. PAI-guided PDT requires a near-infrared contrast agent for deep tissue imaging with minimal photobleaching effect. We evaluate the impact of PDT agent, benzoporphyrin derivative (BPD), on PAI agent indocyanine green (ICG) and vice versa, given that they have different optical absorption properties and singlet oxygen quantum yields for PDT. Specifically, we demonstrate in two oral squamous cell carcinoma lines (FaDu and SCC4) that ICG has minimal effect on BPD PDT efficacy when irradiated with either a continuous or pulsed laser. Furthermore, the impact of BPD on ICG photodegradation was monitored with PAI in tissue-mimicking phantoms. These studies inform us that the combination of BPD and ICG can be utilized for PAI-guided PDT. However, researchers need to consider the photodegradation effects of ICG in the presence of BPD when designing their drug delivery strategies for PAI-guided PDT.

5 March 2025 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Open access
MXMarvin Xavierselvan
Marvin Xavierselvan
RSRonak Tarun Shethia
Ronak Tarun Shethia
BBBrooke Bednarke
Brooke Bednarke
VYVicky Yang
Vicky Yang
LMLeah Moses
Leah Moses
Srivalleesha MallidiSrivalleesha Mallidi
Srivalleesha Mallidi
Hypoxia in solid tumors, including head and neck cancer (HNC), contributes to treatment resistance, aggressive tumor phenotypes, and poorer clinical outcomes. Perfluorocarbon nanodroplets have emerged as promising drugs to alleviate tumor hypoxia. These versatile nanocarriers can also encapsulate and deliver various therapeutic agents, offering a multifunctional approach to cancer treatment. However, a detailed characterization of hypoxia alleviation, particularly the duration of hypoxia treatment drug residence, has not been thoroughly investigated. In this study, we developed and characterized perfluoropentane nanodroplets (PFP NDs) for the codelivery of oxygen and the photoactivatable drug benzoporphyrin derivative (BPD) to hypoxic HNC spheroids. The PFP NDs exhibited excellent stability, efficient oxygen loading/release, and biocompatibility. Using 3D multicellular tumor spheroids of FaDu and SCC9 HNC cells, we investigated the spatiotemporal dynamics of hypoxia within these spheroids and the ability of oxygenated PFP NDs to alleviate hypoxia. Our results showed that oxygen-loaded PFP NDs effectively penetrated the core of tumor spheroids, significantly reducing hypoxia, as evidenced by the downregulation of hypoxia-inducible factors HIF-1α and HIF-2α. Importantly, we demonstrated sustained hypoxia alleviation for up to 3 h post-treatment with PFP NDs. BPD-loaded PFP NDs successfully delivered the photosensitizer into the spheroid core in a time-dependent manner. Furthermore, we evaluated the efficacy of oxygen-dependent treatment modality, namely, photodynamic therapy (PDT) with BPD and oxygen-loaded PFP NDs compared to free BPD. The NDs formulation exhibited superior PDT outcomes, which were attributed to improved oxygen availability during the treatment. This study provides comprehensive evidence for the potential of PFP NDs as a codelivery platform to overcome hypoxia-mediated treatment resistance and enhance PDT efficacy in HNC. Our findings pave the way for further investigation of this promising approach in more complex in vivo models, potentially leading to improved therapeutic strategies for hypoxic solid tumors.